Overview
Dante Omics AI is a biotechnology company operating in the New York artificial intelligence scene[1]. Founded in 2016, the company merges multiomics data with advanced artificial intelligence to drive innovation in precision medicine[2]. The company operates a proprietary platform called the Dante Platform, which it uses to provide results to clinicians, researchers, and individuals[2]. According to available employment data, Dante Omics AI has approximately 68 employees[3]. The company focuses on developing technologies intended to deepen understanding of human biology and support healthcare solutions[2].
Business address: 667 Madison Ave, New York, New York, 10065. [7]
Growth & traction
Key people
Focus
- Dante Omics AI describes itself as "The multiomics information company, specialist in whole genome sequencing and interpretation. Owner of Dante Labs.".[5]
Something wrong or missing? Send an update. Fixed within 24 hours.